Similarly, in the FTC versus normal and benign tissue comparison, the genes CDKN1C, CREB1, FOS, HSPA5, and JUN were also significantly downregulated, corroborating the trends observed in our experimental dataset. The gene discussed is CDKN1C; the disease is thyroid cancer, nonmedullary, 2.